Indaptus Therapeutics, INC. 8-K Filing
Ticker: INDP · Form: 8-K · Filed: Apr 3, 2026 · CIK: 0001857044
| Field | Detail |
|---|---|
| Company | Indaptus Therapeutics, INC. (INDP) |
| Form Type | 8-K |
| Filed Date | Apr 3, 2026 |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Indaptus Therapeutics, INC. (ticker: INDP) to the SEC on Apr 3, 2026.
What are the key financial figures in this filing?
Key dollar amounts include: $0.01 (nge on which registered Common Stock, $0.01 par value INDP Nasdaq Capital Mark).
How long is this filing?
Indaptus Therapeutics, INC.'s 8-K filing is 3 pages with approximately 916 words. Estimated reading time is 4 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 916 words · 4 min read · ~3 pages · Grade level 13.2 · Accepted 2026-04-03 12:00:08
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value INDP Nasdaq Capital Mark
Filing Documents
- form8-k.htm (8-K) — 44KB
- 0001493152-26-015079.txt ( ) — 206KB
- indp-20260331.xsd (EX-101.SCH) — 3KB
- indp-20260331_lab.xml (EX-101.LAB) — 33KB
- indp-20260331_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 104 Cover Page Interactive Data File
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: April 3, 2026 INDAPTUS THERAPEUTICS, INC. By: /s/ Junyi Dai Name: Junyi Dai Title: Chief Executive Officer